Ashenden M - Search Results

1

Modification of gene expression: help to detect doping with erythropoiesis-stimulating agents.

Varlet-Marie E, Audran M, Ashenden M, Sicart MT, Piquemal D. Varlet-Marie E, et al. Among authors: ashenden m. Am J Hematol. 2009 Nov;84(11):755-9. doi: 10.1002/ajh.21525. Am J Hematol. 2009. PMID: 19802893 No abstract available.

2

Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.

Macdougall IC, Ashenden M. Macdougall IC, et al. Among authors: ashenden m. Adv Chronic Kidney Dis. 2009 Mar;16(2):117-30. doi: 10.1053/j.ackd.2008.12.010. Adv Chronic Kidney Dis. 2009. PMID: 19233071 Review.

3

Stability of athlete passport parameters during extended storage.

Ashenden M, Clarke A, Sharpe K, d'Onofrio G, Plowman J, Gore CJ. Ashenden M, et al. Int J Lab Hematol. 2013 Apr;35(2):183-92. doi: 10.1111/ijlh.12014. Epub 2012 Oct 15. Int J Lab Hematol. 2013. PMID: 23067319

4

A third generation approach to detect erythropoietin abuse in athletes.

Sharpe K, Ashenden MJ, Schumacher YO. Sharpe K, et al. Haematologica. 2006 Mar;91(3):356-63. Epub 2006 Feb 17. Haematologica. 2006. PMID: 16503554

5

Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.

Mørkeberg J, Sharpe K, Belhage B, Damsgaard R, Schmidt W, Prommer N, Gore CJ, Ashenden MJ. Mørkeberg J, et al. Among authors: ashenden mj. Scand J Med Sci Sports. 2011 Apr;21(2):235-43. doi: 10.1111/j.1600-0838.2009.01033.x. Scand J Med Sci Sports. 2011. PMID: 19903320

6

Screening for autologous blood transfusions.

Mørkeberg J, Belhage B, Ashenden M, Bornø A, Sharpe K, Dziegiel MH, Damsgaard R. Mørkeberg J, et al. Among authors: ashenden m. Int J Sports Med. 2009 Apr;30(4):285-92. doi: 10.1055/s-0028-1105938. Epub 2009 Feb 6. Int J Sports Med. 2009. PMID: 19199200

7

Net haemoglobin increase from reinfusion of refrigerated vs. frozen red blood cells after autologous blood transfusions.

Ashenden M, Mørkeberg J. Ashenden M, et al. Vox Sang. 2011 Nov;101(4):320-6. doi: 10.1111/j.1423-0410.2011.01493.x. Epub 2011 Apr 28. Vox Sang. 2011. PMID: 21534982

8

Standardization of reticulocyte values in an antidoping context.

Ashenden MJ, Sharpe K, Damsgaard R, Jarvis L. Ashenden MJ, et al. Am J Clin Pathol. 2004 Jun;121(6):816-25. doi: 10.1309/1FAM-1VT3-N76G-JGXV. Am J Clin Pathol. 2004. PMID: 15198353

9

Second-generation blood tests to detect erythropoietin abuse by athletes.

Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG. Gore CJ, et al. Haematologica. 2003 Mar;88(3):333-44. Haematologica. 2003. PMID: 12651273 Clinical Trial.

10

A strategy to deter blood doping in sport.

Ashenden MJ. Ashenden MJ. Haematologica. 2002 Mar;87(3):225-32. Haematologica. 2002. PMID: 11869930 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results